By Puyaan Singh (Reuters) - The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Medically reviewed by Lindsay Cook, PharmD Weight loss medications can be an effective option for people struggling to lose ...

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...

The buy now, pay later model has taken off. Experts say BNPL can be useful when used responsibly, but shoppers should be careful not to overspend.

Mounjaro’s been great,” the comedian said in an Instagram video. “I’m having a really good experience with it and I wanted to keep it real with you about that.” ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Semaglutide is the active ingredient in Wegovy It is also the main component ... “Those considering using semaglutide strictly for weight loss might want to factor in hair loss as a possible ...